documentatiemap als tekstdocument.
Inhoud :
-
Inleiding
-
Geschiedenis
-
Scenar technology
- preface
- Doctors introduction
- Functional explination
- SCENAR-therapy is based on the following principles
- Scientific Basis for a New Medical Paradigm
4) Published Controlled Trials
* he Analysis of Peripheral Blood Changes Following SCENAR-Treatment
* Use of SCENAR treatment for various bone fractures in children
* Health conditions of emergency aid doctors. Chronic Insomnia
* Multifactor mechanism of SCENAR-analgesia
* Effect of arthrophon with use of Transcutaneous Neurostimulation on values of
lipid peroxidation at complex post-surgical therapy in patients with purulent
appendicular peritonitis
* Scenar and emergency
* Comparison Of The Effectiveness Of SMC And SCENAR-Influence In Recovery Of The
Body Functions of Sportsmen After Training
* Abstracts of clinical tests of scenar-devices
1.From the Russian Health Munistry Neurosurgery Institute, Dr. N.P. Burdenko reports
2. Russian Health Ministry. Scientific Research Institute of Pediatrics and Infantile
Surgery.
3. Russian Health Ministry.Russian R.R. Vreden Scientific Research Institute of
Traumatology and Orthopedics.
4. Academician I.P. Pavlov State University , St. Petersburg
5. Central army (military) scientific and research aviation hospital.
* Practical Results of SCENAR's Application
Doctor of "IMPULS-CORRECT" Rehabilitation Centre O.V. Myzova (Tjumen).
Professor Veldishev J.E. (Pediatry and Pediatric Surgery Research Institute).
Dr. Posvezhinskaya N.F. (Volgograd
Drs. Okhotenko V.I., Krasykova M.L., Krasykova N.G. (Pushkin, Zhukovsky)
* Dr. Yuri Gorfinkel Research Results
5) Technical features of the scenar-device
Functions of the SCENAR devices
1 )Inleiding.
SCENAR staat voor Self Controlled Energy Neurone Adaptive Regulator.
Met zijn ongevaarlijke elektrische impulsen werkt de Scenar via de huid op de zenuwen en zet ze aan tot het produceren van stoffen die de cellen en organen nodig hebben om goed te kunnen functioneren.
De Scenar activeert het hele lichaam in plaats van het onderdrukken van de symptomen.
Daarom wordt na de behandeling met het Scenar-apparaat niet alleen de pijn minder, maar treedt ook een algemene verbetering op en krijgt men meer energie.
De Scenar activeert het hele lichaam in plaats van het onderdrukken van de symptomen.
Daarom wordt na de behandeling met het Scenar-apparaat niet alleen de pijn minder, maar treedt ook een algemene verbetering op en krijgt men meer energie.
Bijna 25 jaar geleden kregen een aantal top Russische wetenschappers de opdracht apparatuur te ontwikkelen om voor de goede gezondheid van hun kosmonauten in de ruimte te kunnen zorgen en een EHBO-hulp te kunnen bidden zonder het gebruik van farmaceutische medicamenten, aangezien een ziekenhuis en ambulance in die omgeving niet bereikbaar zijn. Meer dan 50.000 geanalyseerde behandelingen hebben geleid tot de huidige behandelmethode en apparatuur.
Begin jaren negentig, na de val van de muur kwam de Scenar beschikbaar voor medische toepassingen. In Oostenrijk, Zwitserland en Duitsland wordt de Scenar-therapie al veel gebruikt. Maar in Belgie staat deze nog in de kinderschoenen.
Begin jaren negentig, na de val van de muur kwam de Scenar beschikbaar voor medische toepassingen. In Oostenrijk, Zwitserland en Duitsland wordt de Scenar-therapie al veel gebruikt. Maar in Belgie staat deze nog in de kinderschoenen.
2) Geschiedenis.
Prof Revenko, the developer of most of the protocols governing classical Scenar Practice, sees
the evolution of Scenar as follows :
1975
At Taganrog ’s Radiotechnical University
1978
A. Karasev gave one of the few ENS – devices to Dr. A Revenko for trials. He worked at that time in Taganrog Rostov and Taganrog
1980s
The director of OKB “RITM” Vladislav Zacharevich monitored the development of ENS and introduced it to Military and Space organizations.
1985
Revenko suggested a new name – CENAR, Zacharevich introduced CENAR to Alexandr Nechuschkin (President of Russian Acupuncture Association and Expert of USSR Health Care Ministry) and Prof.med. Arseny Medelyanowsky. In Russian, this name sounds like "canary" and at the suggestion of Arseny Medelyanowsky and Alexandr Nechuschkin, CENAR became SCENAR.
1986
Revenko presented first SCENAR to USSR Health Care Ministry in order obtain permission to produce the device and use it in clinical practice. OKB “RITM”, at its factory “Pryboj”, started preparations for the production of SCENAR – devices.
1986, 1987
SCENAR was awarded Silver and Bronze Medals at the Main Exhibition of the USSR
1987
The first SCENAR – patent was awarded to the following five individuals - A.Revenko, A.Karasev, A.Kibirev, V.Zacharevich, A.Nechuschkin. At this same time, OKB “RITM” opened its first Medical Centre, where the first SCENAR practioners were: Peter Kruglov, Alexandr Dogadkin, Yuri Gorfinkel, Leonid Pac, Sergej Pobokin. Revenko simultaneously opened his own Medical Clinic “Biocorrection”, where he practiced SCENAR therapy, together with 10 other SCENAR Practitioners.
From 1989 to Now
Trade mark “SCENAR” absolutely belongs to OKB “RITM” all over the world.
From 1989 to 1995
The engineers of OCB “RITM” (A.Kibirev, M.Zenkin, Y.Koretsky) developed and produced many different types of SCENARs : SCENAR-033 with solar-powered batteries, SCENAR-033M, SCENAR-032, SCENAR-035. During this time A.Karasev continued to work as an engineer in OKB “RITM” until in 1990, he, with the assistance of OKB “RITM”, opened his own laboratory “Let Medical”.
1990
A.Revenko works in Russian Health Care Ministry.
1992
J.Grinberg created new concepts for the marketing and promotion of SCENAR-devices, which included running SCENAR Training Seminars. The first SCENAR Training Seminar was held in Divnomorsky, on the Black Sea ; the first teacher was Alxander Revenko. Since then, SCENAR Training Seminars have been held regularly and A.Revenko invited P.Kruglov, S.Pobokin and Y.Gorfinkel to become his teaching team.
1993
The medical centres of OKB “RITM” and “Biocorrection” were joined to form one SCENAR centre, which became the first SCENAR-clinic in the world. Its principal doctors were A.Revenko and Y.Gorfinkel.
1994
The first International SCENAR conferences were developed, and since then occur regularly.
1996
As SCENAR became very popular the world over, some people felt encouraged to produce copies of SCENAR : first came Boris Vernik with “SCENAR-032A”; next was Armen Avakyan with “AcuSCEN”; then A.Ryavkin with “DENAS”; “Fenzian’ with James Colthust, “Inter-X” with Zulia Frost and her Neuro Energy Group. A.Karasev continues to produce many devices under the name SCENAR, for which he has no permission from OKB "RITM", and commences developing his own trade mark – Cosmodic. OKB “RITM” creates, develops and produces a new device, the SCENAR-97. The principal developers of this model are Misha Unakafov and Max Zenkin, who hold the patent together with A.Revenko, J.Grinberg amd Y.Gorfinkel.
1998
The first international SCENAR Training Seminar took a place in Nassau in the Bahamas
1999
The international production company “Intermediate Services” is established in Holland (it has since been re-named “RITMEDIC”) and commences production of the SCENAR-97 device, under licence from for OKB “RITM” for Europe and the UK
Today in excess of 44 countries in the world know and use SCENAR-therapy.
Present
Every year OKB “RITM” develops new models of SCENAR, improves them, takes out patents, conducts clinical trails, organizes international conferences and publishes articles, books, magazines, etc.
3) SCENAR technology:
Preface
Imagine that you could treat chronic disease without complications and side effects, revitalizing your patients in the process. Imagine you could straighten curvature of the spine without surgery, treat ligaments and tendons with ease, reduce inflammation and allergic reactions quickly and effectively, improve blood vessel tone, regulate and improve hormone and immune systems and rapidly reduce pain. Imagine you could effect fast, intense and long lasting improvement for many hitherto “incurable” illnesses where patients’ best hopes had previously been of symptomatic relief. Imagine.
Experienced Scenar doctors and therapists are achieving these and many other remarkable effects every day. Scenar therapy has evolved over the last 30 years and is producing an everincreasing number of beneficial results; both clinical statistics and testimonials prove the efficacy of this technology. A first class line of Ritmscenar devices and an education and support program for Scenar therapists has been developed, in order to meet the fast
growing worldwide demand for Scenar therapy.
Doctor’s introduction
For more than 10 years my colleagues and I have been using Scenar therapy as the main treatment in our medical clinic. It took me a few years to change my classical approach to medicine and realize the
potential of Scenar therapy to restore the body to a healthy state. We have treated over 3000 patients with the help of Scenar therapy. In more than 75% of cases patients’ experienced complete recovery and the remaining had a substantial improvement in their condition. These results have proved to me that Scenar therapy is the best therapy for chronic
diseases. We now consider it as a ‘new’ kind of medicine. One that can be used on it’s own or alongside pharmaceutical medicine. One of the benefits of Scenar therapy is that it successfully stimulates the body to produce
neuropeptides – a vital step in the healing process with no side effects.
With the advent of this technology my ability to treat patients has widened enormously. Many of my patients could not be helped with traditional medicine; Scenar therapy has helped all of them.
Yolanta Stanchak
Doctor & Scenar instructor
Functional explanation
Grinberg Y., Taganrog , Russia
SCENAR-Therapy And SCENAR-Diagnostics
SCENAR-therapy is based on the following principles [1, 2, 3]:
1 . The neuropeptides (NP) together with the classical neuromediators (NM) and the other humor regulators ensure all compatible biological activities in norm and pathology (the concept of functional continuum of regulative peptides). NP are characterized by the ability to create complex regulative chains and cascades, their long life span, their distant effects and action onto the genome activity. The following vector represents a formal description of this concept
Х = {х1, х2, ..., хn} (1),
where хi (i- from 1 to n) are its components, e.g. the quantitative values of mediators
(amines, amino acids, purine nucleitides) and regulative peptides (RP).
2 . The neuro-secretive cells, obtaining dual characteristics – of a neuron and of a endocrine cell, are scattered around the whole organism and are localized both in the different parts of the brain and in the peripheral nervous fibers (the concept of distribution in space). Formaly vector (1) can be defined (measured) at any point of the organism, its components being different in the general case.
3 . Any physical action on the organism, in this case electro-action, is always a disturbance of homeostasis. The neuro-endocrine system coordinates all vital processes in the organism, forms a functionally united mechanism and ensures the regulation of homeostasis in case of its disturbance (the principle of reaction). There is a hierarchy that exists among the neuro-endocrine mechanisms of regulation, which is closely connected to the speed of development and decrease of hormonal signals and also to the molecular mechanisms of their actions.
In case of deflection from the norm of one or another process of vital activity, the nervous system is the first to get involved, NM are secreted (a certain part of the components of vector 1), which by changing the activity of ion channels will cause hyper- or de-polarisation of membranes. This regulation of cell activity, which is due to physical processes, develops and diminishes in fractions of a second (seconds).
If the nervous system of regulation is not able to bring one or another factor of homeostasis back to the norm, the peptide hormones will be involved, acting through membranous receptors and the system of secondary mediators stimulating the chemical modification of proteins. Concomitant accumulation of peptides with stress-limiting spectrum of action is taking place. This regulation is due to chemical processes, develops and diminishes for minutes or tens of minutes.
If the deviation from the norm reaches dangerous for the body values, steroid and thyroid hormones will be involved, which due to the specificity of their receptors have an influence on the gene expression. This reaction is realized in 3-6 hours and diminishes in 6 – 12 hours after the deviation of the process from the norm. The growth factors take an intermediate position, as their receptors are capable of penetrating into the nucleus and leads to proliferation of the cells.
4 . In order to achieve therapeutic effect, the physical action has to provide the release of effective dose of RP at minimal damaging for the organism effect (the principle of effective therapy). The therapeutic action is also a disturbance of homeostasis. It leads to its deflection from the norm established at the moment in the organism or at the region of action. Accumulation of peptides (with stress-limiting spectrum of action including and part of the components хi of vector 1) is taking place, and they are practically aiming to cope with the disturbance induced by the therapeutic process. Their excess, if I may say so, is used by the organism in the struggle with pathology.
5 . The organism is capable to react adequately (in its own benefit) to the disturbance of homeostasis, at least to these changes, which are induced by the therapeutic (not big) doses of the physical action (the principle of self-regulation). This is the most important principle of vital activity – the organism is aiming to achieve a beneficial adaptive result.
The principle of self-regulation is closely connected with the principle of reaction, it only gives accent on the achievement of a beneficial adaptive result from the reaction. The principles described above make it possible to explain the therapeutic results, to make a comparison of the therapeutic methods (not only of electrotherapy) and alongside with model (1) to introduce a number of terms.
We will define Хn with components Хin as the vector corresponding to the condition of organism in norm and Хp with components Хip as the vector corresponding to the condition of organism in pathology. This idea is confirmed by the change in Хi (in correspondence with the principle of reaction) in the neuro-humour regulation of cardio-vascular, respiratory system, reproductive function, gastro-intestinal tract, inflammatory and tumour processes as well as during shock.
The transformation of Хn into Хp – these are the compensatory reactions of the organism to the biological, anatomical and functional disturbances in accordance with the principle of self-regulation, the “wish” of the organism to preserve homeostasis under the concrete conditions of pathology. This to a considerable extent resembles the dominating nowadays molecular concept of pathology: a predominant number of pathological processes start with a certain damage of cell membranous structure and as a consequence a change in the components of vector Х follows.
Simultaneously, processes directed from Хp to Хn are taking place in the organism. But it is possible that the organism will not go back to Хn, but it will put up with” a certain conditional norm Хnc (e.g. a condition of chronic pathology). And as Хn depends on time, it is always better to accept it as a certain conditional norm.
When the regulatory reactions are not adequate, which leads to unfavourable course of disease, quite often long lasting, therapy has to be provided. Within the frames of the accepted formalization, therapy is a special external action on vector Хp (opposite to the compensatory reactions, which take place even without this action) leading it to Хn (Хnc). Specific therapy is a deliberate (direct or indirect) action on a certain part of components xk...xl (where m=(l-k) << n). Nonspecific therapy is the activation of those components, due to which normalization of vector Х occurs independently from the causes for its alteration.
The above principles and model (1) aim to explain the questions about therapy.
The interaction electrode / skin plays a substantial role for studying the processes, concerning biofeedback, expertise, diagnostics, as well as for the exploration of the processes of interaction of the current with organism and the evaluation of the influence of the place of applying the electrodes [4].
In direct contact of the metal (or an equivalent) electrode of the device with the skin, the metal come in contact with a complex water solution, containing a number of electrolytes – inorganic as well as organic. The arising potential difference (a double electric layer) along the border metal/ solution is called an electrode potential. Its equivalent electrical scheme –the parallel connection of capacity and resistance. The formation of the double electric layer is accomplished for a certain interval of time. [5] Later on, electrochemical reactions between the metal and the solution arise, which are connected with the local metabolism. A change in the electrode potential and capacity of the double layer takes place.
The resistance to constant current on the metal-skin boundary is very high, while that to the alternate current is considerably lower and is determined by the frequency of the latter. But even for the alternate current the resistance of the subcutaneous liquor of the organism is considerably lower especially when using electrodes with comparatively small surface. From the above it follows that:
-for electrotherapy what is important is not the way of current passage through the organism but the concrete places for applying the electrodes;
-respectively, the difference between compact and scattered application of the electrodes is not of principle importance;
-the basic processes in electrotherapy are taking place in the interaction with the peripheral nervous structures (see Table).
In the light of the above, we will dwell in greater detail upon the perspectives of SCENAR diagnostics.
As it was mentioned earlier, the initial formation of the double electrical layer is accomplished for a certain interval of time. This determines the first (fast) phase of management of parameters of the device acting signal.
Electrochemical reactions between metal and the solution, connected with local metabolism, take place later on. A slow change in the electrode potential and the capacity of the double layer occurs. This, together with the reaction to the acting signal, determines the subsequent dynamics of the signal. It is the characteristics of this dynamics, along with the skin reactions to the action – asymmetries, small asymmetries, secondary signs [6,7], which are used for SCENAR expertise. These very characteristics are also the basis of development of SCENAR diagnostic procedures.
LAYERS OF IRRITATION RECEPTORS FIBRES
|
LAYERS OF IRRITATION
|
RECEPTORS
|
FIBRES
|
|
Epydermal
|
Tactile electroreceptors
|
Аb
|
|
Dermal
|
Tactile, pain and temperature exteroreceptors, endings of the vegetative perivascular nerve fibres
|
Аb, Аd, В, С
|
|
Subdermal (myofascial incl.)
|
Proprioreceptors, endings of the vegetative perivascular nerve fibres
|
Аa, Аg, В, С
|
|
Periostal
|
Pain, tactile and temperature exteroreceptors, endings of the vegetative perivascular nerve fibres
|
Аb, АD, В, С
|
At the same time the problem of choosing of the zones (points) of influence of signal parameters, materiel, size and configuration of the electrodes still remains to be solved as well as the necessary statistical studies to be conducted. Mind that in using metal electrodes the omic resistance electrode-skin is very high (tens of KiloOm), while the resistance to alternate current is substantially lower. Nevertheless, especially in using point electrode, this resistance is much
higher than the one measured in the liquid medium of the organism. That is why the basic voltage drop occurs on a limited (in depth) area of the skin. Respectively, when studying the mechanisms of diagnostics, it is necessary to pay special attention to the processes taking place in the superficial layer and the corresponding nerve endings (see table).
The information in this document is provided by RITM OKB ZAO, Taganrog , Russian Federation
Interactive Neuro Feedback SCENAR
Scientific Basis for a New Medical Paradigm
Dr. John A. Hache DNM
The Human Genome project has revealed humans to possess a mere 25,000 or so genes, only 50 per cent higher than the number possessed by fruit flies, and our genome is not only 99 per cent or more identical with that of chimpanzees, which is well known, but about 35 per cent identical to daffodils Thus, apart from our genetic complexity, biological models, whether sea urchins or mice or humans, all have one thing in common. And that is the development of their
ectoderm. In embryology, the ectodermal tissue involves the early development of the brain or nervous system, the organs of special sense, the epidermis, and epidermal tissues such as fingernails, hair and skin glands. The reason for this of course is communication with the outer world. So how do you influence the nervous system? How do you disturb its millisecond by millisecond business and create a new priority?
Without them it would probably be as if we were in a coma. Unable to receive
sensory messages we would remain oblivious to what was happening around us.
So the ectodermal tissue and the senses become a clue to the complex new
medical paradigm that was to unfold, born of necessity.
It is considered that during the flow of consciousness, there is never a break in the constant stream of brain activity. Anticipations and habits are the most common place activities for the brain. In the cycle of awareness, the brain begins with expectations and intentions, and then the moment happens. A split second later, the brain begins to map the sensations, extracting the meaning of the moment. The conscious results then become fodder for the next moment. Everything is perfectly seamless. In more modern terms, it is said that the brain is assailed
by 40 billion bits of information every single second – most of it routine.
It will deal with approximately three million bits of information, deeming the rest to be rather non‐vital for the instant. Such mundane activities as beating of the heart, pulsing of the gut , production of new blood cells ,maintaining of proper Ph levels, blood sugar levels, mitosis, digestion etc. all demanding their fair share of energy. These three million bits focus on regulation and interventions which may be vital to the systems survival – so better
take care of these before lapsing into a “watch and see” mode. So the Russians question was – “How to break into the brain’s list of priorities, all it really takes is one 500 hundred of a millisecond to set new goals and expectations.”?
had well described and laid out his functional systems theory in his work entitled
“The Functional System”, following years of research using mice as his study model. This was carried out
at the Department of Systemogenesis, P.K. Anokhin Institute of Normal Physiology,Moscow , Russia
Finally they chose a high frequency of (50 to 100 Hz) which would cause 20 times more
healing peptides than low frequency (1 to 4 Hz). They found that
the body would quickly adapt to low intensity high frequencies and stop responding. High intensity, high frequency,
bipolar signals of less than 100 mili‐seconds per phase were thus chosen.
In essence, Anokhin and others were discovering the molecular and electromagnetic basis for cybernetics. The modern definition of cybernetics is “the study of communication and control
within and between humans, machines, organizations, and society”. A distinguishing feature of this broad field is the use of feedback information to adapt or steer the entity toward a goal. When this feedback signal is such as to cause changes in the structure or parameters of the system itself, it appears to be self‐organizing. Many healing modalities are now regarding
diseases processes as blockages in informational and organizational pathways. This becomes more evident in the Traditional Chinese Medical view called Acupuncture as well as its horizontal and vertical meridians. In the above figure, we are looking at the cellular cascade and amplification. A single antigen, hormone, pheromone, growth factor, or smell or taste or neurotransmitter molecule, or a single photon of electromagnetic energy, can produce a cascade of intracellular signals that initiate, accelerate, or inhibit biological processes. This is possible because of enormous amplification – a single molecular event at the cell surface can trigger a huge influx of calcium ions, each of which can activate an enzyme. The enzymes are not consumed by these reactions, and can therefore act repeatedly, some of the reactions are sensitive to electromagnetic fields, some are not, and others have not yet been tested. Some frequencies enhance calcium entry, others diminish it. Steps in the cascade involving free radical formation are likely targets of magnetic fields. Some of the products of the cascade are returned back to the cell surface and into the surrounding extracellular space. Molecular events within cells set up electronic, photonic, and electromechanical waves (phonons) that
propagate as solitons through the cellular and extracellular matrix. These feedbacks enable cells and tissues to form a functionally organized society. The cells whisper to each other in a faint and private language. They can “tune into” each other over long ranges. (James Oshman, Energy Medicine – The Scientific Basis – Churchill Livingstone)
The technology that was developed by the Russians is unique as it engages all of the body’s natural resources to effect a healing moment. By incorporating a Biofeedback modality called GSR or Galvanic Skin Response, the device’s electrodes are capable of picking up differences in the skin’s electrical conductivity. Stimulation of the traumatized area forces the body to reorganize itself as receptors on the cell surface become the primary sites of action of the low frequency electromagnetic fields. The calcium channel becomes the amplifier for the reorganizational process as described by James Oshman in his groundbreaking work. The Russians chose 60 Hz as their default frequency, as it was found to
greatly increase calcium influx compared to weaker or stronger frequencies used in other systems. The device’s on screen ability to identify changes in the skin’s properties through biofeedback becomes a valuable asset to the therapist in being able to identify optimal treatment locations. Once the optimal treatment locations are identified, high density treatment using the multi mode treatment options are applied to the specific nerve
endings that have been disrupted by the injury.
No Scientific Basis for energy Medicine –
Medicine according to The Shorter Oxford English Dictionary, is ‘the science and art concerned with the cure, alleviation, and prevention of disease, and with the restoration and preservation of health’. Medical Schools don’t emphasize electronics, bioenergetics, bioelectricity or other subjects that would create a noteworthy medical awareness of the electrical and electronic phenomenon occurring within the body. So up to now, vested interests in pharmaceutical approaches cry that there is no Scientific basis for energy Medicine but when we look closer we realize that it is impossible to separate energy from Medicine. In fact energy is vital to the survival of all biological models. The Science is all around and within us.
ATP
Energy is required for cells to do the things they need to do. The healing response requires energy, oxygen, nutrients, etc. ATP is the energy molecule in the body that drives cellular energetic process. Cellular activities are able to repair injuries but at an extremely high energetic cost in the process. Cells require energy to propel them from place to place. Cells must be able to deliver Oxidative bursts called Reactive Oxygen Species (ROS) with which
to attack pathogens, they must have the energy to reproduce – energy to divide – they must be able to provide secretions of all sorts in and around sites of injury. ATP production is vital to the survival of the body. The store of ATP in a human body is sufficient to satisfy a person’s needs for only a few seconds; therefore, the store needs to be replenished continuously. For example the heart function is responsible for running the sodium, calcium, potassium ion pump. More ATP is required to relax the heart muscle’s fibers. When ATP levels fall, so does
myocardial function. So the mechanical efficiency of the heart as well as protein synthesis requires extremely high levels of ATP. When there is a general drop in ATP levels, there will be a drop in Ph levels and a subsequent drop in electrical potential at the cellular level. This would spell disaster as disease caused by opportunistic bacteria, yeast, fungus, etc. would soon thrive in a milieu that no longer has the strength to protect itself. In the mid 70’s, (1974) George Palade and Albert Claude won the Nobel Prize for their painstaking work that they
were to present to the Nobel Committee. It was in a field that they themselves would create. Their discoveries concerning “Structural and Functional Organization of the cell” was a breakthrough in modern cell biology. By developing a method for the separation of the contents of the cells they would elaborate on just what the little organelles inside of cells were doing. Mitochondria are sometimes referred to as the ‘powerhouses’ of the cell because they are the sites in which the Krebs cycle and electron transport system generate large amounts of ATP. The electron transport chain involves a series of protein that pass electrons from one molecule to another. The result is a concentration gradient across the mitochondrial membrane and energy of that gradient is used to create ATP. In principle, the mitochondria
exhibit semi‐conductor like activity. So as we can see, the electron transport chain needs electrons to function properly. The electron transport chain can run into an electron deficiency. By exciting electrons locally it is possible to increase the production of ATP.
Tiny magnetic fields through the law of induction will induce the flow of micro currents in the tissue. These fields are in the micro ampere range so the client does not necessarily sense these currents flows but they may have a dramatic effect by allowing the cells to do the things that they need to do for the completion of injury repair, cell reproduction, leukocyte production and stimulation for the digestion of debris and other energy requirements.
So when introducing electrons via the Scenar, you stir up and add to existing electrons that are highly mobile, affecting their movement through the transport chain and consequently an increase in the production of ATP. Thus by powering the various activities of the cells, a big change can be immediately seen in the patient. In all illness, it is vitally important to keep ATP levels high. ATP can also be bolstered by giving Magnesium, ribos, CoQ10 and LCarnitine supplements.
Antioxidants to the Rescue
Inflammation is basically a protective mechanism. The leakage of water and protein into the injured area brings humoral factors, including antibodies, into the locale and may serve to dilute soluble toxic substances and wash them away. The adherence and migration of leukocytes brings them to the local site to deal with infectious agents.
But things can get complicated when pockets of inflammation become stagnant. In fact the latest medical hypothesis is that inflammation may be responsible for the general breakdown of the body. This new hypothesis states that virtually all chronic disease is caused by inflammation. Deep in connective tissue may be little lumps, old injuries not resolved – tiny pockets of inflammation that may seep over time causing occult damage elsewhere
downstream and may hold the answer to strange degeneration of tissue in the kidneys for example. The events are never confined to the focus of trouble. Free radicals or unpaired electrons are believed to be the culprits in the inflammatory event. Prostaglandins and tiny molecules called cytokines are responsible for tissue breakdown as blood flow through the zoned off area slows down. The Scenar can stir up electrons, pairing them up within the site of inflammation. This would bring to a close a healing process that can be 20 years old and was never resolved. This can be particularly true in the CNS where pockets of inflammation can be protected from treatment by the blood brain barrier. The BBB inhibits movement
of drugs and anti‐inflammatory agents within the brain itself. Electrons can traverse the blood brain barrier pervasively as if it never existed.
Scenar Development and Trials
During 30 years of Scenar development, Universities and medical specialists have focused on the following areas:
• Bronchi pulmonary system
• Cardiovascular system
• Nervous system
• Gastro enteric system
• Uro‐genital system
• Endocrine glandular system
• Immune system
• Bones‐muscles‐ligament system
• Dermal system
• Emergency trauma treatment
• Pain Management
For each of these areas, the contribution of Scenar therapy for health recovery has been defined and tested. This has resulted in specific treatment schemes and protocols for those areas as well as generic, non‐specific treatment schemes that are applied to treat the body in an integrated way. SCENAR is an acronym which stands for “Self Controlled Energo neuro Adaptive Regulation”.
In summary, it has been proved that Scenar therapy provides effective support for:
* Chronic diseases
* Curvature of the spine
* Traumas like sports injuries, operations, skin burn, bone fractures
In addition, it can be concluded that Scenar therapy:
* Is non‐invasive
* Causes no complications
* Has no negative side effects
* Leads to reduction of the use of medicine
And good to know that it is also reported that in most cases it will bring the patient:
* Better sleep
* Healthier appetite
* A happier disposition
4) Published Controlled Trials
The Analysis of Peripheral Blood Changes Following SCENAR-Treatment
Analysis was conducted on the influence of SCENAR-treatment in peripheral blood changes. The dark-field and phase-contrast microscopy of native peripheral blood were used for the analysis.
The analysis was carried out according to the following pattern:
• Initial blood sampling with microscopy and photo-video-recording;
• SCENAR-treatment on the site of puncture for blood sampling and on the symmetrical point (distal phalanxes of ring-fingers). SCENAR-2-NT (version 01) was used for the treatment, the settings were as follows: F=90 Hz, Intens=3, Gap=10 for 5 min;
• Blood sampling (from both fingers) followed by microscopy and photo-video-recording immediately after the SCENAR-treatment;
• Blood sampling (from both ring-fingers) followed by microscopy and photo-video-recording 60 min after the SCENAR-treatment.
58 people were tested: 32 female aged 24-42 (average age 27.6), 26 male aged 25-45 (average age 29). All tested subjects were defined as almost healthy.
In the course of the analysis it was found that the immediate response to SCENAR-treatment developed as follows:
1. The blood coagulated faster (first fibrin fibers become visible in 30 sec-1 min, normally – in 1-2 min and later);
2. The amplitude of amoeboid movements of leucocytes increased;
3. Visible uric acid crystals were much smaller than before SCENAR-treatment.
Long-term results of SCENAR-treatment were as following:
2. The ratio of the number of erythrocytes to the liquid part of plasma changed as follows: liquid part of plasma increased, its fluidity improved.
3. Better marked amoeboid movements of erythrocytes;
4. Phagocytic activity of leukocytes increased greatly;
5. The number of echinocites considerably decreased (almost by half).
Immediate changes in the peripheral blood following SCENAR-treatment were provided by local tissue stress reactions aimed to protect it from local damage. At the same time blood coagulated much faster, and the activity of blood corpuscles increased. Long-term changes were provided by both local and general autonomic reactions. We should emphasize that these significant, general bodily changes were produced by treatment of small areas (zones) for a short time. We should also pay attention to the effect SCENAR-treatment has on the blood acid-base balance. This is obvious from the decrease in the number of echinocites which are the specific markers of blood acidosis.
Effects:
1. SCENAR-treatment considerably accelerates blood coagulation;
2. SCENAR-treatment improves flow properties of the blood;
3. SCENAR beneficially influences central mechanisms of peripheral hemodynamic regulation;
4. SCENAR beneficially influences the mechanisms of blood acid-base balance regulation.
Conclusion:
SCENAR is a powerful non-specific regulator of the processes supporting the internal balance of the body, even as a monotherapy, it is sufficient to provide fast and pronounced change in hemodynamics, rheology and tissue reactions.
The information in this document is provided by RITM OKB ZAO, Taganrog , Russian Federation
Use of SCENAR treatment for various bone fractures in children
One of the principal causes negatively affecting the health of children is locomotor trauma.
A constant growth is being observed in the number of permanently handicapped children due to injuries and diseases of the skeletal and locomotor system. Statistically, over 600,000 bone fractures are diagnosed in children and teenagers annually in Russia 10 241 in 2001 to 12 816 in 2006.
The number of especially grave injuries is also on the rise - in 2006 42 children under 14 years old were left with permanent disabilities.
The Child Traumatology department in Rostov-on-Don is based at the city hospital No.20, where an orthopedic & traumatology department (75 beds) and a child traumatology ward have been functioning since 1976.
The child traumatology department is one of the country’s largest, its location at a multi-profile hospital allows for specialized care for both injuries and diseases of the locomotor systems. The department serves as the study base for the Child Surgery and Orthopedic Chair of the Rostov State Medical University
Outpatient care is extremely important for child traumatology, as (provided outpatient care is well-funded and correctly administered) up to 95% of all injuries in children can be treated without hospitalization. Incoming patients with injuries are treated in the traumatology center of the city hospital No.20, which provides first aid, outpatient care, follow-up of patients discharged from hospital, monitoring patients with traumatic after-effects and preventive work in the child traumatology field.
The modern standards of aid in limb fractures incorporate a combined approach to treatment. The main procedure is closed manual repositioning of fragments, followed by gypsum cast immobilization. If repositioning fails (fragments remain displaced) operative treatment is used. Starting from early post-operative period the patients receive courses of medications, physiotherapy and physical therapy exercise.
Bone fracture, causes in the trauma zone, and a source of irritation that launches the mechanisms of reparative regeneration - bone healing (formation of bone callus). The healing process proceeds in stages. Early, within 3-4 days the primary blastome is formed - a preparation stage when materials for the regeneration are stockpiled. Between the 3-4 and 12-15 days the second reparation stage begins - the stage of forming and differentiating tissue structures, with scar or cartilage tissue regeneration. The third stage is called the “angiogene structure formation and regeneration matrix mineralization” – at this stage the bone callus formation takes place between 12-15 days and lasts till the first to second month. The fourth and final stage, when the secondary reconstruction and restoration of the original bone structure takes place, can continue for months.
The changes are not only local; the blood pressure, heartbeat, breathing measurements, blood and urine analysis demonstrate profound post-traumatic changes.
Materials and methods:
Our goal was assessing the effect of SCENAR therapy in treating children with various bone fractures.
The patients (32 children aged 4 to 17, 21 boys and 11 girls) were admitted to the hospital in the acute period (1 to 3 hours following injury) with local pains, swellings, deformations.
All underwent X-ray, general blood and urine analysis.
The children were randomly distributed into two groups. The first group (13 patients - 9 boys, 4 girls) received SCENAR treatment. The second, control group (19 patients - 12 boys, 7 girls) underwent traditional treatment.
SCENAR treatment was administered daily using the SCENAR 97.5 device, in constant and individual measured modes. The course consisted of 5-8 sessions of 20-40 minutes duration. Both general zones (”three pathways and six points”) and reciprocal areas on the symmetric limb were treated. Of all medications, only analgesics (during the two first days) were administered.
Results and discussion:
In 5 of the patients already the first SCENAR treatment session had greatly relieved the pain. In 7 more the first session showed improvement in microcirculation (decreasing the swelling), by the 3-4 treatment session none of the patients complained of pain. By the end of the treatment course none of the patients exhibited neuro-circulatory disorders, all were in satisfactory condition. At the same time in the control group the pain subsided only by the 2-3 day of treatment, a visible decrease in swelling took as much as 4-5 days.
Depending on the fracture complexity, control X-rays were made 1, 2, 3 or 4 weeks later. After discharge from hospital all patients were monitored at the city traumatology center, where X-rays were also undertaken at the time.
The average time for the appearance of primary bone callus in SCENAR-treated children was 25,6 ± 2,4 days, while in the control group the same took 33,5 ± 2,5 days.
It must be noted that independent of the fracture complexity, all patients accepted SCENAR therapy well, not a single case of worsening the condition was observed.
A few X-rays protocols to demonstrate the effect of SCENAR:
Kurnosenko M.V., aged 15 13.02.07 - 25.02.07
Diagnosis: Closed fracture of the right humerus medial epicondyle with dislocation of fragments. Closed dislocation of right forearm bones to the rear. Injury caused by fall on ice. On arrival, the dislocation had been set. Operation – open repositioning of the epicondyle fracture, pin ostheosynthesis after Papp. The gypsum cast was removable, allowing direct SCENAR treatment of the injured limb.
On the 1st day following surgery, right elbow joint circumference on the shoulder side was 28,0 cm , on the forearm side 28,5см; the difference form the intact elbow was, therefore, +6 cm . After the first session, on the 2nd day the difference decreased by 2,5 cm .
Diagnosis: Closed transverse fracture of the right radius in the lower third part, with dislocation of fragments. Injury caused by falling from a swing. Manual repositioning, gypsum cast immobilization.
On the 21st day X-ray bone callus formation was visible; cast removed, regenerative treatment commenced.
Bagiryan A.G. aged 14 12.02.07 - 12.03.07г
Diagnosis: Closed transverse fracture of the left radius, with moderate fragment dislocation. Gym fall injury. Gypsum cast immobilization. The X-ray taken on the 28th day showed formation of bone callus. The misalignment of fragments was within the cortical layer width. Cast removed, regenerative treatment commenced.
Blood analysis dynamics:
On 12.02.07. Er-4,5х1012/l; Leuk- 9,6х109/l; Нb-149g/l; eosionophile-0, p-6, s-76, lymphocytes-16, monocytes-2. On 13.02.07. Er-4,4х1012/l; Leuk- 9,0х109/l; Нb-146г/l; e-0, p-5, s-76, l-16,
м-3. On 14.02.07. Er-4,1х1012/l; Leuk- 6,2х109/l; Нb-135г/l; e-1, p-1, s-66, l-30, м-2. Before discharge 19.02.07. Er-4,2х1012/l; Leuk- 5,7х109/l; Нb-140g/l; e-1, p-1, s-60, l-36, м-2.
Shochev D.H. aged 6. 08.01.07 - 05.02.07
Diagnosis: Closed transverse fracture of the right radius, mid-lower third part with dislocation of fragments. Injury caused by a fall at home. Manual repositioning, gypsum cast immobilization.
Already on the 8th day the X-ray demonstrated signs of bone callus formation. The callus formation completed by 28th day, cast is removed, regenerative treatment commenced.
Dynamics ОАК On 08.01.07. Er-4,1х1012/l; Leuk- 8,0х109/l; Нb-134g/l; e-1, p-1, s-67, l-29, м-2. On 09.01.07. Er-4,0х1012/l; Leuk- 6,6х109/l; Нb-131g/l; e- , p-2, s-71, l-17, м-10 Before discharge 13.01.07. Er-4,5х1012/l; Leuk- 5,3х109/l; Нb-140g/l; e-4, p-2, s-58, l-24, м-12
Аnsimov А.V, aged 7. 05.01.07 - 17.02.07
Diagnosis: Closed spiral fracture of the right tibia, middle-lower part with moderate dislocation of fragments. Skating accident injury. Fragment repositioning, gypsum cast immobilization. The control X-ray demonstrated bone callus formation. Cast removed, regenerative treatment commenced.
Conclusions: Thus, the new non-invasive electric impulse treatment technology allows the decrease of fracture consolidation time in children by 7,3 ± 3,1 days, stimulating the bone tissue reparation, without side effects and complications. This allows the application of gypsum casts for a shorter period time and the commencement of combined regenerative treatment earlier.
The information in this document is provided by RITM OKB ZAO, Taganrog , Russian Federation
Health conditions of emergency aid doctors. Chronic Insomnia
Among the doctors a steady tendency of incidence rate was noticed, as chronic forms prevail in the structure. A special group consists of emergency aid doctors, which work in conditions of deprivation of sleep, which is one of the reasons of chronic insomnia.
Purpose of the research.
Revelation of sleep disorders in doctors of mobile emergency teams, comparative analysis of influence of pharmaceutical and physiotherapeutic methods and condition of free-radical oxidating and anti-oxidant protection (AOP) of the organism.
Materials and methods.
Adapted enquirer of Spiegel was used, haemodynamic parameters were evaluated, study of condition of lipid peroxidation was performed, as well as anti-radical protection in blood plasma and erythrocyte before and after treatment.
342 doctors of mobile emergency teams were questioned in South Federal district . Average age was 44.9, term of service was 13.8 years.
Results.
165 doctors (48.3%) had normal parameters of subjective evaluation of sleep, 96 doctors (28%) had borderline disorders, 81 doctors (23.7%) had chronic insomnia. In this arm, pre-insomnic (difficulties of falling asleep) and intrasomnic (quality of sleep, number of night-time awakenings) disorders were found. Insomnia statistically did not depend on the period of service and the age. In patients women it was noted twice more frequent.
Among the patients there were 2 groups. Group 1 – 53 doctors which took Zopiklon (Imovan) dose size 7.5mg for 10 days 30 minutes before supposed sleep. Group 2 – 20 people had 10 procedures of transcutaneous treatment with SCENAR. The treatment was performed during the holiday.
Positive effect was noted in 96-94% of patients, regardless of the type of therapy. 30% of the patients were examined 1 month later – sleep disorders were not noted. Treatment with Zopiklon and SCENAR for chronic insomnia reliably improved almost all the subjective characteristics of sleep (apart from its duration).
Analysis
showed that SCENAR influences mostly intra- and post-somnic disorders. Comparative analysis of lipid peroxidation and anti-oxidant protection after the end of the course of electroneurostimulation and treatment with Zopiklon showed that SCENAR-therapy decreases to a bigger extent the intensity of oxidative stress and increases the anti-radical protection of the organism.
The suggested method of treatment of chronic insomnia, compared with pharmaceutical method, does not have side effects and complications, it has a limited list contraindications, it has no contraindications for age and is compatible with pharmaceutical treatment of other diseases.
The article is provided with the assistance of:
RITM OKB ZAO
Petrovskaya 99
RITM Australia Pty Ltd
www.scenar.com.au
Multifactor mechanism of SCENAR-analgesia
Summary:
The complex effect of SCENAR-therapy is demonstrated in situations of emergency, when various conditions associated by acute pain are treated. The result of monotherapy of pains: proved analgesic effect at traumas (n=20, 60%); analgesia against a background of normalized function of the system of organs at stenocardia (n=26, 66%) and hypertensive crises (n=153, 88-91% for cephalgia, and cardialgia respectively).
The issue of protecting patients against pains has an enormous humanistic importance. Pain is a signal of danger, a symptom of many diseases, main reason for patients to suffer, basic pathophysiologic factor of developing shock.
When a patient faces aversive factors of ambience, adaptive mechanisms start so that the organism survives in new conditions. Activation of endogenous antinocieption system is one of these general biologic mechanisms. It is proved that realization of endogenous antionociception is performed through opiate and non-opiate systems of brain. Mechanisms of antinociception have been subject of numerous comprehensive works, including acupuncture, electropuncture, and transcutaneous neurostimulation. [2,3,8,11]
It is known that pharmaceutical methods of analgesia are imitation of the functions of endogenous system to protect against pain. They are important when performing mass analgesia. Starting the endogenous antinociception system is optimal when methods of reflexotherapy are used, and this method is more physiologic. The complexity of the methods, their invasiveness, impossibility to be used in extreme circumstances, lack of reliable and inexpensive equipment, and insufficiency of trained specialists are the factors that obstruct mass introduction of reflexological methods of analgesia.
Methods of transcutaneous bioregulated low-frequency impulsive electrotherapy have been used recently for non-pharmaceutical treatment [5,6,7], particularly – self-
Multifactor mechanism of SCENAR-analgesia Page 2
controlled energy neuroadaptive regulator (SCENAR). This method is based on the effect of bipolar impulsive points of low frequency without constant component. Characteristics which distinguish SCENAR among electric equipment for transcutaneous stimulation: 1) optimal form oh the impulse and the force of the effect; 2) the body almost does not have to adapt to SCENAR impact due to biotechnological feed-back; 3) non-damaging mode of impact; 4) high level abruption of the front of the affecting signal with neutralization of the accommodation effect; 5) many researches have been performed to examine this method of treatment; 6) during the treatment an expert evaluation of the dermal condition can be used to optimize the area of impact; 7) optimal construction of the appliance enables it to work in various conditions [6, 7].
Applying SCENAR-therapy is an issue of huge interest due to its availability, rapid positive effect, simplicity of treatment and steady result.
TASKS OF THE RESEARCH
Examining possibilities to perform SCENAR-therapy at various pathological processes accompanied by acute pain in conditions of emergency.
MATERIALS AND METHODS
Mobilizing adaptive systems of the organism using SCENAR in conditions of acute damage of their functions and analgesic effect were the reason to use the appliance in emergency situations. More than 40 doctors of emergency departments in 13 towns of district of Rostov, Stavropol Taganrog
SCENAR-therapy was performed according to instructions [12], as dermal areas with located “anti-pain” points were included; if needed methods of general treatment can be added: “three paths on the backbone and six points on the face” and “ collar area, forehead, adrenals”. If there was no possibility to affect the injured organ, “work” with the appliance was performed on symmetric areas. The kin was treated using CHENS-SCENAR appliances without digital methods in mode F1. The therapeutic procedure was performed only once by an emergency department doctor, as the duration of the procedure was 5-30 minutes long, depending on the effect. When the analgesia was ineffective, the doctor could inject analgesic medicine. To evaluate the effect of the analgesia in conditions of emergency, a visual analog scale (VAS) was used, where 0cm = lack of pain, 10cm = maximum pain.
The use of itineraries subject to the method “three paths” of the backbone and six points of the face was performed on the grounds of the following: when processing path 2 and 3, Shu-points of the back are included in the area of the impact of SCENAR (points of consent)[4, 10, 11], which are located on the urethra. The itinerary of path 1 is a non-pair rear middle meridian. When areas containing points VG1-VG4 are processed a therapeutic effect is marked on this channel at nervous system diseases, intestinal diseases, diseases of the urino-genital system. When areas containing points VG5-VG8 are processed a therapeutic effect is marked on this channel at nervous
Multifactor mechanism of SCENAR-analgesia Page 3
system diseases, diseases of gastric and intestinal system. The area of points from VG9 to VG14 - nervous system disorders, pulmonary diseases, fever.
Processing six points on the face enables to input information through all the three ramifications of the trigeminus nerve. On the other hand biologically active points of the channels are located in these areas. At least point V2 of the urethra, points E2 and E3 of the gastric channel and G120 of the large intestine, and point E4 of the gastric channel are included in the area of impact of SCENAR.
The method “collar, forehead, adrenals” is also related to the areas of general treatment. The use of itineraries in this method is performed due to largely represented reflexogenic areas and biologically active points as the experience of SCENAR-therapy shows [5, 12]. When the indicated itineraries are processed and when the dermal areas are processed “according to instructions”, the appliance may stick. In this case the electrode is not unstuck from the skin but is held on it until further movement becomes possible. If the appliance does not stick, then other kinds of so-called asymmetry can appear (hyperimia, change of the characteristics of the sound, different sensibility etc.). These dermal areas are processed additionally until initial characteristics are changed.
RESULTS AND DISCUSSION
1. Pain at traumas. Analgesia with the use of SCENAR was performed at small and medium traumas: lower limbs fracture (n=5), injuries of soft tissues – limbs, thorax, without damaging respiratory functions (n=9), I and II degree burns of face and abdominal wall (n=2). Cut wounds and bites (n=4). There were nine men and 11 women with age from 11 to 82 (average age – 40.7±3.9). The patients were treated using general means of treatment: splinting, immobilization, non-adhesive bandages in cases of burn etc. The evaluation of the pain was performed using VAS before the analgesia with SCENAR, immediately after the procedure, and in the 10th and 20th minute. In the same periods of time other complaints and symptoms were defined, as well as the parameters of hemodynamics. The data is shown on fig.1.
Fig.1. A - Dynamics of the analgesic effect of SCENAR during therapy of
traumatic pains according to VAS.
B – Dynamics of systolic and diastolic blood pressure and pulse frequency of patients with traumatic pains. Reliability referring to data before SCENAR: * - P < 0.05; ***- P < 0.001;
A distinct reliable analgesic effect developed immediately after the procedure, almost without further increase by the 20th minute. Observations showed that the analgesic effect increases by the 50th – 60th minute. Because the emergency staff cannot follow the efficiency of the procedure for a long period of time, in several cases the doctor made the decision to inject additionally non-opiate analgesic medicine (analgine, ketorolac or ketonal). Only 8 out of 20 patients were injected analgesic medicines. Natural skepticism and caution should be noticed when doctors tested the new method.
We regard as an important factor the steadiness of the values of blood pressure. Reliable decrease of the average frequency of cardiac contractions from 85 to 81 beats per minute indirectly shows sympathetic tonus. Reliable change of respiratory
Multifactor mechanism of SCENAR-analgesia Page 5
frequency was not noticed and it was within normal limits. Decrease of other symptoms and complaints was noticed along with the analgesic effect, such as dizziness, nausea, excitedness and sensation of inhibition.
Independent analgesic effect developing on the background of steady parameters of blood pressure end decreasing of symptoms accompanying the traumas is noticed during the process of analgesia using SCENAR for patients with small and medium traumas.
2. Pain at steady stenocardia tension of I-III functional class.
26 patients with ischemic cardiac disease, crises of pain at steady tension stenocardia of different functional classes were treated with SCENAR, as the patients had previous idiosyncrasy to nitrates or lack of efficiency of the nitrates. There were 14 men (average age – 63,1,7±2,5 years old), 12 women (average age - 68.4±3.7 years old). 7 patients had arterial hypertonia as accompanying disease, and 3 of them had osteohondrosis of the backbone. This category of patients was additionally treated with SCENAR as the dermal area of the pericardial channel was processed in the lower part of right forearm and the painful area of skin on the thorax.
Fig.2. A – Dynamics of the complete analgesic effect and number of residual
pains (%) during analgesia of patients with attacks of stenocardia.
B - Dynamics of analgesia of patients with residual pains during
SCENAR-therapy, according to VAS. Reliability referring to SCENAR data: * - P < 0.05; ** - P < 0.02; *** - P < 0.001.
As can be seen in fig.2 (A) immediately after SCENAR-treatment the pain completely disappeared for 46 % of the patients and for 65% of the patients – 20 minutes later. 35% of the patients felt residual pain in the 20th minute of the treatment, but the intensity of the pain was much less, which can be seen in fig 2 (B). These patients, among whom there were mainly patients with accompanying diseases, were offered additional therapy with included symptomatic medicines and non-opiate analgesics. Changes of parameters of blood pressure and pulse statistically did not differ for the category of patients with additional treatment and patients with SCENAR-therapy.
This way, analgesia using SCENAR for algic crises at steady tension stenocardia causes sufficient independent analgesic effect, which does not depend on parameters of general pressure. The extent of its correlation with coronary varicose and the endogenous mechanisms which SCENAR starts in order to stop the pain, can be defined in hospital conditions and additional tests.
3. Cardialgia and cephalgia at hypertensive crises.
During SCENAR-therapy for patients with neurovegetative form of hypertensive crises normalization of parameters of blood pressure was aimed, not only analgesic effect. A total of 153 patients were helped at their homes on emergency call. To analyze the analgesic effect we divided the patients into 2 groups: with cephalgia (n=137, which forms 90% of the patients; among them 71 patients – 52% had cardialgia); separately data of patients with cardialgia were analyzed (n=78, which is 51% of the patients). Patients of this category were treated by SCENAR, as the skin was processed in the collar area, area of pericardial channel, in the lower part of the right forearm, and dermal projections of maximal pain.
Fig.3. A – Dynamics of the complete analgesic effect and number of residual pains (%) during analgesia of patients with cardialgia at hypertensive crisis.
B - Dynamics of analgesia of patients with residual pains during SCENAR-therapy, according to VAS. Reliability referring to SCENAR data: * - P < 0.05; ** - P < 0.02; *** - P < 0.001.
In fig. 3 can be seen that immediately after the procedure cardiac pains disappeared for 61% of the patients, and for 91% by the 30th minute. Nevertheless, residual painful sensations were registered by the 30th minute only for 9% of the patients. Their extent was much lower, as at stenocardia, which could be seen during evaluation using visual analog scale (fig. 3 B). This category of patients at times needed an additional injection of non-opiate analgesic.
In fig.4, the effect of the appliance can be seen for cephalgia and hypertensive crises at pre-hospital stage of treatment. Fig.4 A shows reliable and gradual elimination of pain. After the procedure the headache disappeared for 43%, and for 88% of patients - by the 30th minute.
Multifactor mechanism of SCENAR-analgesia Page 8
Residual pains by the 30th minute were registered only for 12% of the patients. Their extent, according to VAS, was much lower than before the procedure (fig.4 B). Unidirectional elimination of pain in cardiac area and headaches was noticed during elimination of hypertensive crisis. We analyzed the changes of parameters of blood pressure during SCENAR-therapy.
Some patients took hypotensive medicines before the emergency staff arrived, which dramatically changes the efficiency of SCENAR. Naturally there was certain skepticism: was it SCENAR that affected or was it previously taken medicines?
Fig.4. A – Dynamics of the complete analgesic effect and number of residual pains (%) during analgesia of patients with cephalgia at hypertensive crisis.
B - Dynamics of analgesia of patients with residual pains during SCENAR-therapy, according to VAS. Reliability referring to SCENAR data: * - P < 0.05; ** - P < 0.02; *** - P < 0.001.
This is why we divided all the patients into 2 groups: ones who took medicines and ones who did not took medicines before they called the emergency and were treated with SCENAR. Among the patients who had taken hypotensive medicines before the emergency arrived (calcium antagonists, β-adrenoblockers, APF inhibitors etc) 30-90 minutes before that without any effect there were 80 people (58 women, 22 men; average age – 61.1±4.9 years old). The group of patients who did not take medicines before calling the emergency contained 73 people (52 women, 21 men; average age – 63.1±3.5 years old). The results are shown in fig.5.
As can be seen in the left part of the figure, the parameters of blood pressure for both groups did not differ before and after SCENAR-treatment, on the background of general decrease of blood pressure. 30 minutes before the end of the procedure the systolic blood pressure decreased 11-16% , diastolic – 11-9%. This speed of decrease of blood pressure in the first 30 minutes is effective as cardialgia and cephalgia are eliminated it is safe for all ages. A typical effect of the SCENAR-therapy is the primary elimination of the complaint of the symptom and then normalization of objective parameters. Vegetative corrective effect of SCENAR–therapy should be noticed as hyperhydrosis, nausea, vomiting and excitedness is eliminated. Further observation of some patients and the experience of elimination crises in hospital conditions show that average blood pressure decreases 15-25% within 1 hour, which does not lead to ischemia of targeted organs. The reliable decrease of frequency of cardiac contractions with 9% could be noticed when eliminating crises without previous use of medicines (fig.5b)
Fig.5. A – Dynamics of parameters of blood pressure during SCENAR-therapy of hypertensive crises in the group of patients who had taken and who had not taken hypotensive medicines before the emergency staff arrived.
B - Dynamics of frequency of cardiac contractions in the same groups. Reliability referring to the data before SCENAR: * - P < 0.05
Fig.6. Dynamics of correlation coefficient depending on the decrease of systolic blood pressure and decrease of painful sensibility at cephalgia and cardialgia, according to VAS.
If during the process of analgesia the analgesic effect develops independently for patients with traumas, then during attack of pain at steady stenocardia and particularly hypertensive crises, the analgesia probably depends mostly on recovering of functions and decrease of ischemia: the decrease of system blood circulation and normalization of regional blood circulation including the coronary one.
We analyzed the dynamics of correlation coefficient depending on the decrease of systolic blood pressure and the extent of headache and cardiac ache, according to visual analog scale. The data is represented in fig.6. As can be seen in this figure the correlation coefficient increases simultaneously with the decrease of the systolic blood pressure and decrease of values of extent of cardialgia and cephalgia, according to VAS. If in the beginning of the crisis the extent of the pain did not depend on the values of blood pressure, then SCENAR-therapy led to increase of the correlation to 0.41 and 0.48. Similar dynamics of close relation and its lack in the beginning of the crisis probably shows simultaneously developing effects of SCENAR: analgesic effect and the effect, which normalizes the functional system of blood pressure regulation. This way, the elimination of neurovegetative form of hypertensive crises using SCENAR regardless of preliminary therapy leads to gradual decrease of parameters of blood pressure and frequency of cardiac contractions. Distinct analgesic effect of cephalgia and cardialgia is noticed, which probably has a mixed nature.
During the process of elimination of acute pain with different origins, three elements should be present in the algorithm: possible elimination of reason causing pain; affecting the sensation of pain - perception; possible prophylactics of pathophysiological damages, which pain causes or will cause.
As the experience of work with SCENAR shows, during the treatment of acute and chronic painful syndromes, the data presented in this article show the multicompoundness of the suggested therapy. Non-medical method of elimination of acute pain starts the endogenous antinociception and other mechanisms of recovering damaged functional systems. The analysis of the data obtained in traumatology and cardiology shows that the share of perceptual component of SCENAR analgesia is
Multifactor mechanism of SCENAR-analgesia Page 12
different depending on nosology, the level and the volume of the damage. It is not reasonable to rely on only one single method of analgesia and it is also dangerous for the patient, especially in case of emergency.
Undoubtedly, the morphologic substrate of the analgesic effect of SCENAR-therapy are the antinociceptional systems of brain, started from the different areas of skin. SCENAR works with the biologically active points, with their accumulation and the surrounding tissues – this a zonal appliance. Due to its technical solution, it “finds” these points independently. As shown for acupuncture analgesia [8], in opioidergic, serotoninergic, catecholaminergic, cholinergic, gamkergic and possibly other mechanisms take part in its realization.
Some authors regard the transcutaneous electro-stimulation as the most accessible and the simplest “hyperstimulation analgesia” to be realized. If we proceed from the theory of Melzack and Wall (1965) the activity in the thin non-myelinized C-fibers located in the jelly substance of the rear horns of the spinal cord “opens the gates” to the further pass of nervous impulses bearing the information of pain. The role of the thick fibers consists in the ability to “close the gates”. One of the hypotheses of the analgesic effect of transcutaneous neurostimulation consists of the fact that the procedure leads to activation of thick myelinic fibers with subsequent “locking the painful entrance”. The analgesic effect during the so-called dynamic neurostimulation is proved to be naloxone-dependent [9].
Using almost the same methods of SCENAR-therapy and taking under consideration the principles of heir application [5,6,12], we obtained unidirectional results: analgesic effect and final positive sanogenic result connected with normalization of the changed functional system. Taking under consideration the limited volume of such a publication we can mention that similar unidirectional results were obtained during the process of therapy of acute myocardial infarction, burns, bronchial asthma of adults and infants etc.
The simplicity of use of SCENAR allows us to recommend the use of this kind of analgesia in any conditions and if needed, by people without medical education.
Multifactor mechanism of SCENAR-analgesia Page 13
CONCLUSIONS
1. The SCENAR-therapy (self-controlled, energy neuro-adaptive regulator) is an effective, safe and multifactor non-pharmaceutical method of analgesia during treatment of different conditions accompanied by acute pain in cases of emergency.
2. During the process of analgesia using SCENAR the patients with small and medium trauma (n=20), an independent analgesic effect is noticed (60%) developing on the background of steady parameters of blood pressure and decrease the symptoms accompanying traumas.
3. The analgesia of algic attacks at ischemic disease and steady tension stenocardia (n=26) using SCENAR, causes a sufficient independent analgesic effect (66%), which does not depend on the parameters of general pressure.
4. The elimination of neurovegetative form of hypertensive crises (n=153) using SCENAR, regardless of preliminary medical therapy leads to gradual reliable decrease of the frequency of cardiac contractions and decrease the parameters of blood pressure by the 2oth minute after the procedure; by the 30th minute a distinct analgesia of cephalgia and cardialgia is noticed (88-91% respectively).
The article is provided with the assistance of:
RITM OKB ZAO
Petrovskaya 99
RITM Australia Pty Ltd
www.scenar.com.au
Effect of arthrophon with use of Transcutaneous Neurostimulation on values of lipid peroxidation at complex post-surgical therapy in patients with purulent appendicular peritonitis
The tumour necrosis factor-alpha (TNF) plays a significant part in inflammatory destruction of pathogenesis.
Purpose :
to explore the influence of arthrophon in respect of its bipathic effect combined with transcutaneous neurostimulation (SCENAR-therapy) on the state of lipid peroxidation, values of endogenous intoxication at treatment of patients with purulent appendicular peritonitis in post-surgical period.
Materials and methods:
58 patients were examined who were operated for purulent peritonitis. All the patients were treated with conventional intensive therapy. In group 1 (n =38) treatment combined with SCENAR was performed. In group 2 (n=20), four tablets per day of arthrophon were additionally prescribed, plus 5 procedures of SCENAR-therapy. The control (n=36) – healthy donors comparable as age and sex. Evaluation of efficiency was performed according to clinical and laboratory data on the first and fifth day from the start of the treatment. Application of arthrophon led to decrease of the level of myeloperoxidase with 50.1% (p<0.001). The activity of catalase increased with 41% compared with the initial background (p<0.02) and reached the control group. In both groups, statistically reliable decrease of malondialdehyde (MDA) was noted as well as decrease of diene-conjugates on the 5th day of the treatment. The level of intoxication was defined according to the fraction of medium-mass molecules in blood plasma. After a five-day course of therapy in the first group the contents of medium-mass molecules (280) decreased with 28.8% (p<0.01), in the second group – with 39% (p<0.001). In the second group, decrease of medium-mass molecules was noted – 30.3% (p<0.05), in the first group a reliable change of this value was not noted. On the background of arthrophon and SCENAR-therapy, the level of circulating immune complex dramatically decreases 5 days after the treatment – 40.3% (p<0.01).
Conclusions:
arthrophon combined with SCENAR-therapy proves to be an effective therapeutic means for post-surgical period in patients with purulent appendicular peritonitis. A significant decrease of clinical symptoms of the disease was noted, as well as normalization of paraclinical values. The combined therapy allows to correct faster and more efficiently the extent of endogenous intoxication, which were evaluated with reliable decrease of some fractions of medium-mass molecules and circulating immune complex. Arthrophon and SCENAR-therapy combined with basic intensive therapy in post-surgical period in patients with purulent appendicular peritonitis decrease the intensity of processes of lipid peroxidation on the 5th day, increase anti-oxidant protection and improve the function condition of cellular membranes.
The article is provided with the assistance of:
RITM OKB ZAO
Petrovskaya 99
RITM Australia Pty Ltd
www.scenar.com.au
SCENAR AND EMERGENCY
Background :
Every year every 3rd citizen of Russia
of them is admitted to a hospital. Over the last 10 years the number of calls for emergency
increased by 33%, and the share of patients admitted to the hospital on an emergency basis
increased almost three times. Emergency is the most mass kind of rendering medical aid in
workers are employed in this field. At the same time available drugs are insufficient for actual
needs, and standards for medical aid rendering are behind the economic situation.
The research objective
was to test new non-drug techniques (SCENAR-therapy) for rendering medical assistance.
Materials and methods.
The research involved emergency stations in Rostov-on-Don, Nizhni Novgorod, Stavropol , Pyatigorsk, Zheleznovodsk, Kislovodsk, Essentuki, Azov, Bataisk, Taganrog , Maikop, Penza
The clinical research was carried out using a specially made map.
The data of 610 patients that were rendered SCENAR first aid have been analyzed in the article. 47.8% of patients took drugs before the emergency arrived.
When rendering SCENAR first aid, the following effects from using the device are the
most important for emergency: analgesia, functional recovery, anti-edema action, pathological
processes become less evident and proceed faster, patients feel much better.
Here are the most frequent reasons for the emergency calls:
cardiovascular diseases:hypertension strokes – 153, neurocirculatory distonia – 32; stable angina pectoris attacks – 26,algic syndromes and symptoms: osteochondrosis with various radicular pains -77; myofascial syndrome – 16, intercostal neuralgia – 8; contusions, fractures, haematomas – 20; acute respiratory viral infections, rhinosinusitis, rhinopharyngitis – 33; acute bronchial asthma – 16; gastroduodenal diseases – 9, and more than 10 other nosologies and syndromes. In the article we’ll describe the SCENAR-therapy effects in patients with traumatic injuries of extremities and soft tissue bruises (n=20); coronary heart disease, stable exertional angina pectoris (n=26); cardialgia and cephalgia at hypertension strokes (n=153).
Anesthesia with SCENAR was used for slight and moderately severe injuries: closed
fractures of legs (n=5), soft tissue bruises – those of extremities, chest, with unimpaired
respiration (n=9), I-II degree burns of face and abdominal wall (n=2), scalping type and bite
wounds (n=4). 9 males and 11 females, aged 11 to 82 (average age – 40.7±3.9).
26 patients with coronary heart disease, pain attack at stable exertional angina pectoris that
had intolerance to nitrates or in whom the earlier nitrate therapy turned out to be ineffective, were SCENAR treated. 14 males (average age – 63.7±2.5), 12 females (average age – 68.4±3.7). 7 patients had arterial hypertension, 3 patients – spinal osteochondrosis, as their concomitant diseases.
When rendering SCENAR first aid to patients with neurovisceral hypertension strokes, our purpose was not only to relieve pain but also to normalize their blood pressure. 153 patients in all were rendered assistance by emergency doctors at home.
Findings.
One should keep in mind that pain is unpleasant sensations and emotions due
to actual or possible tissue damage. Doctors and doctor's assistants often deal with the emotional reaction to pain manifesting itself as suffering and with pain-specific behavior that allows the doctor and people around the patient to understand that the patient feels pain. Unlike analgesics, SCENAR being a customized personal treatment allows to relieve pain and influence both the perception and emotional component of pain.
The analgesia was clinically assessed using 10 and 3 point visual analogue scale.
When traumatic pain was treated, patients felt acute pain. SCENAR was used following
the user’s instructions provided with the device. When assessing the analgesic effect using the 10 point scale, pain relief was established in almost every case. Before SCENAR treatment the pain was esti estimated as 8.8±1.4 points on average. Right after the treatment and 20 minutes later it was assessed 3.9 and 3.2 points (Р<0.001). Analgesia time varied from 30 minutes to 4-7 hours. When relieving pain from stable angina in patients of I-III functional classes, a clear analgesic effect was defined during and right after the procedure. At 3-point scale the pain reduced from 2.6±0.7 to 0.6 immediately and to 0.5 at the 20th minute after the SCENARtreatment. Later on the residual pains were relieved with Metamizole Sodium.
When relieving cardialgia and cephalgia in patients with neurovisceral hypertension
crises, the tactics of SCENAR-treatment was first of all aimed at decreasing their high blood
pressure. Taking into account the fact that the patients might have taken antihypertensive drugs before emergency arrived, they were divided into 2 groups. The analysis showed that the drugs taken before the SCENAR-procedure neither affected nor potentiated the SCENAR-effect. On average, their blood pressure decreased 15-20% of the initial mean-dynamic arterial pressure. It has been clearly determined that SCENAR more reliably reduced the heartbeat rate from 80.3±2.4 to 74±1.7 beats per minute (Р<0.05) in patients who took no drugs before SCENARtreatment. Cardialgia and cephalgia almost completely disappeared after 20-30 minutes. Algic syndromes and symptoms in osteochondrosis with radicular pains – n = 77. Patients were divided into 3 groups with pain mainly in the neck, head, chest and low back regions. 4 point scale was used to assess pain. The data were analyzed and evident analgesic effect was proved in all 3 groups. Pain decreased from 3 to 0.2-0.5 points on average on the 20th minute after the treatment. Normal hemodynamic characteristics were registered.
Summary:
1.SCENAR is an effective medical instrument for rendering first medical assistance
2.SCENAR action: relieves pain, recovers functions, accelerates the clinical course of a
pathological process, and decreases its the evidence.
3.The eventual beneficial effect is 87-92.3% irrespective of prior drug therapy.
4.Patients spend less on drugs and subsequent rehabilitation.
5.The number of medical errors decreases greatly.
6.The findings may recommend that SCENAR should be used for rendering self- and
mutual help until an emergency arrives.
A.V.Tarakanov
Comparison Of The Effectiveness Of SMC And SCENAR-Influence In Recovery Of The Body Functions of Sportsmen After Training
It is well known that the “recovery” of sportsmen after muscle activity is an extremely important and topical problem.
We understand that under “recovery”, complex processes take place in the organism that lead to normalization of the physical and psychological capacity after different kinds of strain. In order to make the optimal choice, a comparative analysis of the effectiveness of the great variety of methods for recovery including those, used in sports, needs to be done.
Purpose of the research.
The aim of the study was to evaluate the recovery effect of the sinusoidal modulated currents (SMC) and SCENAR-influence on the biological parameters of the blood of sportsmen in training conditions.
Materials and methods.
96 athletes were studied over a period of 10 days. The parameters of the carbohydrates metabolism (concentration of glucose and lactic acid in the blood), the protein metabolism (protein and urea levels, CPC, ALT, AST enzymes), water-mineral exchange (K+, Na+, Ca2+, Cl-), the level of testosterone and cortisone, Hb and pH levels were measured. Blood samples were taken three times: in the morning, on an empty stomach, before training; immediately after training; and after 10 days. The sportsmen were divided into 3 uniform groups of 32 persons each: control group, group with application of SMC (Deviatkina methodics, 1998), and a group treated with SCENAR.
Findings :
According to the acquired results, in the control group, normalization of some of the biochemical parameters was observed, indicating recovery processes after the strain. It was observed that there was recovery in a greater number of parameters in the group with SMC in comparison with the control one. Yet not all parameters were normalized in 10 days. In the third group recovery of all parameters, respectively the body functions, was observed.
Conclusions:
Thus SMC and SCENAR influence optimize the body functions of the sportsmen in the recovery period and could be recommended for sports rehabilitation.
SCENAR was shown to be a more effective method of influence.
The informtion in this document is provided by RITM OKB ZAO, Taganrog , Russian Federation
ABSTRACTS OF CLINICAL TESTS OF SCENAR-DEVICES
1. From the Russian Health Munistry Neurosurgery Institute, Dr. N.P. Burdenko reports:
The device was applied to patients with post-cerebrospinal traumas ranging in age (from 6 months to 4 years), with extremity paresis, pelvis disorders, and sore spots.
All patients experienced increased activity in their extermities, , and pain was either reduced or entirely eliminated. Patients with urinary disorders also improved. Without any special treatment of additional zones, cardio-vascular and digestive functions were normalized.
Approved by Deputy Director of Scientific Research Professor, F.A. Serbienko.
2. Russian Health Ministry.
Scientific Research Institute of Pediatrics and Infantile Surgery.
Scientific Research Institute of Pediatrics and Infantile Surgery.
At the Pediatric Psychoneurology Department, medical tests were conducted with children from 4 months to 3 years old, with arrested motor development and post-delivery trauma.
In all cases, there was a positive response. Children became more active, emotionally balanced, and growth disorders decreased. Patients did not have an adaptive response to treatment, so results were optimal.
Approved by Professor Y.E. Weltishev, Director.
3. Russian Health Ministry.
Russian R.R. Vreden Scientific Research Institute of Traumatology and Orthopedics.
Russian R.R. Vreden Scientific Research Institute of Traumatology and Orthopedics.
The SCENAR device was used on a group of post-surgicalbones and joints patients. All patients experienced reduced edema of operated limbs, fast relief of inflammatory effects, and fistula closures. Patients with algetic and radicular syndrome felt experienced fast pain relief and overall improvement.
Approved by Professor N.V.Kornilov, Director.
Approved by Professor N.V.Kornilov, Director.
4. Academician I.P. Pavlov State University , St. Petersburg
Research was conducted for three months, Dec. 1997 through Jan. 1998, in the Fourteenth Child Health Center
Approved by doctor O.K.Moskvichev, Head of Pediatrics Chair.
5. Central army (military) scientific and research aviation hospital.
SCENAR-032 applied at patient's group suffering of vertebral column and joints problem, lesion of central and periferal nervous system at different degrees and terms, vegetative and trophic disorders, disturbances of pain and surface sensitivity. In all cases quick diminishing of neurologic disturbances were observed, more pronounced under acute processes. Positive organism's reaction as the response at instrument (apparatus) exposure, are still go on for some days after it's application.
Approved by hospital's head on research, candidate of medical science A.P. Kozlovsky.
Practical Results of SCENAR's Application
Doctor of "IMPULS-CORRECT" Rehabilitation Centre O.V. Myzova (Tjumen).
During the October, 1993 to May, 1994 about 145 men, women and children (including new-born children and old people up to the age of 67) addressed for help on the occasion of nervous system diseases, osteochondroses, neuralgia, neuriti s, trauma and inflammatory diseases of CNS, cerebral circulation's disorders, VNS diseases, arthritis, arthrosis, soft tissues injuries, fractures, tracheitis, bronchitis, pneumonia, pleurisy, bronchial asthma, cardiovascular diseases, ischemic heart dis ease, trophic ulcers, microcirculation's disorders, oedemas, gastritis, cholecystitis, colitis, entheritis, renal and urinary Duct's diseases and other pathological states.
The analysis of treatment results has shown that 97,5% of patients have got stable positive changes both subjective and objective. Most of patients suffering from bone-muscle system diseases felt the painfull sensations disappearance
Professor Veldishev J.E. (Pediatry and Pediatric Surgery Research Institute).
Clinical tests were done with 30 children in the Baby Neurology Dept. The apparatus was applied for paretic patients after neurites and birth trauma (15 cases), for patients with accompanying URI (3 cases), and involuntary urination (2 cases). Children aged 4 months to 3 years. No negative reactions were observed. Positive effect was observed in all cases, namely muscle tone got steadily normalized. Involuntary urination ceased, catarrhal accompaniments had got reduced in shorter peri ods.
Dr. Posvezhinskaya N.F. (Volgograd
During 1992 - 1994 years SCENAR was used for the group of patients aged 1,5 months to 85 years. The absolute recovery was achieved in 63% of patients, considerable improvement was attained in 28% and slight improvement - in 9%. SCENAR’s invest igation possibilities concerning the definition of the origin of pathological process and treratment period were confirmed.
Drs. Okhotenko V.I., Krasykova M.L., Krasykova N.G. (Pushkin, Zhukovsky)
The treatment was carried out at Moscow , St.Petersburg and Zhukovsky City Hospitals
Conclusion:
SCENAR-therapy provides positive effect in wide range of nosologic forms taking place in practice. SCENAR can be used both for acute and chronic diseases. SCENAR-therapy carrying out from the very beginning of the disease, especially on the first day, provides fastest positive effect, including post-insult patients.
Dr. Yuri Gorfinkel Research Results
Dr. Yuri Gorfinkel - This name will forever associated with the SCENAR. To many
SCENAR therapists he is a teacher, to a few he was a friend. And if we consider
SCENAR World a living system, than Dr. Yuri was its heart and soul.
This dedication opened the 4th digest "SCENAR therapy and SCENAR
assessment" released in 1998 in Russia
On the 13 April 1998, on the 37th year of his life, death picked out the best. Y. V.
Gorfinkel - one of the founders of SCENAR therapy, has left this world. He was born on
22nd July 1961. After graduation in 1984 at Rostov State Medical Institute (Rostov
was working as a medical doctor, on call for the emergency services. In June - December
1986 he took part in the liquidating of the Chernobyl
In 1988 he joined, as a SCENAR therapist, the Special Design Bureau RITM "Rhythm". In
1994 he became a consultant for SDB and a trainer and one of the founders of SCENAR
therapy schools.
Dr. Yuri lived a short, but bright life. Being introduced to SCENAR therapy in 1986, he
instantly recognized the great potential of this direction. He took part in the development of
methodology of SCENAR as well as in designing of technical means. One of the
modifications of the SCENAR was called 035-G.
Y. V. Gorfinkel was an initiator of the development of one of the versions of SCENAR -
the "Prologue" device. Dr. Yuri was a pioneer in application of the device in emergency
medicine, the author of the methods of the device use in a subjective mode, the use of
small asymmetry, secondary factors, "the last feature" and various other approaches. The
idea of "SCENAR-vaccination" and many other original ideas belong to him.
Dr. Yuri's involvement in the creation of a new direction in traditional medicine -
SCENAR therapy, is unquestionable and hundreds of followers throughout the whole
A bright memory of Dr. Yuri Gorfinkel will live in our hearts forever.
On the following pages we offer you a summary of Dr. Yuri's experience as a SCENAR
Specialist as he personally put it together and presented to Dr. Irina Kossovski, at her
request, in January 1998, 3 months before his untimely death.
5) Technical features of the scenar-device
SCENAR is acronym for Self Controlled Energetic Neuro Adaptive Regulator. Working on the surface of the skin*, SCENAR finds and then treats pathological skin points, concerned with the disease. We call these skin points "asymmetric points."
The SCENAR device speaks on Human Body's language, producing electric impulses, similar to the natural signals of the cells. That's why it can restore link between regulation center (brain) and the internal organs of the human body. It is well known that pathological conductivity of signals is the main cause of the diseases. Then organism starts to cure itself, because it becomes aware of the disease location.
SCENAR not only assists in the acute phase of the condition, but also helps organism to eliminate chronic processes, achieve balanced state and improves natural capability of the body to resist pathological influences in future.
In general SCENAR is an instrument which does not cure, it just lets the body to detect the problem and to treat this problem. That's why SCENAR is an absolutely safe** device - human body can not hurt itself.
SCENAR device produces pulse bipolar current without constant component.
|
Form of SCENAR Impulse without load.
|
Form of SCENAR Impulse on-load (the device contact with the skin)
|
Different variants of SCENAR impulses on-load depending on skin resistance. The form and duration of impulse changing all time during the treatment because skin resistance dynamically changing too.
|
|
|
|
|
Functions of the SCENAR devices
|
Functions
|
Descriptions
|
Purposes of applying
|
|
2 General Modes of applying
|
1. Subjective Dosed Mode (subjective diagnostic and therapy mode). This mode turned on when "Diag off" indicated on the screen.
2. Individual Dosed Mode (digital diagnostic and therapy mode). This mode turned on when "Diag 1 or 2" indicated on the screen. |
1. To subjectively find "Asymmetry" points (pathological, deviation areas) in general and then treating them
2. To digitally find "Asymmetry" points (pathological, deviation areas) in general and then treating them
|
|
Wide range of power
|
The device have scale of powers from 1 to 250 with step 1.
|
We set comfortable power (energy) level individually at the beginning of the session. For some individuals it can be 10, for others 60 or more. In some cases like emergency conditions or severe pain we need to set high energy level up to 250.
|
|
Wide range of frequencies
|
15-350 Hz
|
Low frequencies 15-60 Hz applies for degenerate conditions, high ones (120 and more Hz) - for inflammatory. High frequencies applies for acute pain relief also, low ones - for chronic or uncertain pain or complaint.
|
|
Frequency Modulation (FM)
|
If the frequency modulation turned on, the device generate different frequencies: from 30 Hz to 120 Hz to 30 Hz to 120 Hz etc.
|
To get the faster and better results on patients, who have uncertain pain or complaint or who can't efficiently respond to fixed frequencies.
|
|
Amplitude modulation (AM)
|
Preset Power Level/Minimal Power Level Ratio by time (in seconds) 5:1, 4:1, 3:1, 2:1 or 1:1.
|
During acute pathologic process it is recommended to use 3:1 AM Mode and then turn on 1:1 Mode. During chronic process we start from 3:1 AM Mode and then use 5:1.
|
|
Intensity
|
Intensity - number of waveforms within one bundle (bundles per second = Frequency). There are 8 steps of intensity - from 1 to 8
|
High Intensity (4 and more) can be applied in case of acute inflammation or severe pain. They have a powerful local effect. Low Intensities have general effects.
|
|
Damping (waveform modulation)
|
Damping - changing form of impulse during treatment. There are 6 Damping variants:
- Damping Sk1 - Damping Sk2 - Damping Sk3 - Damping Sk4 - Damping Var (combination of previous variants) - Damping Off |
In the acute phase of the disease with evident symptoms we apply Sk2 or Sk3. In the phase of decreasing symptoms it is recommended to apply Sk1 or Damping Off mode.
|
|
Gap variants
|
Gap is interval between impulses within bundle. (bundles per second = Frequency). It can be set at 10 - 80 (200 microseconds to 1600 microseconds).
|
We use high Gap (more than 40) if local signs of the disease predominate over the general ones. If general signs predominate over local ones, we use low Gap (10).
|
|
Swing modes (combined modulations).
|
There are four Swing Modes in SCENAR 1 NT 02.1:
1. Sw1 Mode include frequency modulation "on" + Intensity 3 + variable Gap (10-80) + Damping Var 2. Sw2 Mode include frequency modulation "on" + Intensity 3 + variable Gap (10-25) + Damping Var 3. Sw3 Mode include frequency modulation "on" + Intensity 3 + variable Gap (10-73) + Damping Var 4. Sw4 Mode include frequency modulation "on" + variable Intensity (1-4) + variable Gap (10-80) + Damping Var |
We use different types of Swing Modes if we don't have ability or time to select suitable regimens for individual.
|
* The skin is one of the main informational organs of the body. The skin develops together with the nervous system from the same leaf of the fetus during the very first period of fetal life. Some Russian scientists call skin "peripheral brain".
**The other reason of device safety is its very superficial penetration of impulses - skin penetration is not more than 1 millimeter - it is just informational penetration
5) Referenties
Jakov Grinberg
General Director of OKB RITM ltd, medical research and development centre inRussia
General Director of OKB RITM ltd, medical research and development centre in
Jan de Jong
Director of Russian-Dutch joint venture Kosmed International B.V., licensed manufacturer and exclusive distributor in the European Union of OKB RITM Scenar devices.
Director of Russian-Dutch joint venture Kosmed International B.V., licensed manufacturer and exclusive distributor in the European Union of OKB RITM Scenar devices.
Phone: +31 (0) 118 479180
Telefax: +31 (0) 118 479157
Email: Dit e-mail adres is beschermd tegen spambots. U heeft Javascript nodig om het te kunnen zien.
Website: www.ritmedic.com
Telefax: +31 (0) 118 479157
Email: Dit e-mail adres is beschermd tegen spambots. U heeft Javascript nodig om het te kunnen zien.
Website: www.ritmedic.com
Prof. Dr. Alexander Revenko
Med. Professor ofScenar Academy
Med. Professor of
Gerd Raetzel
Med. Doctor -University of Berlin University of Ulm
Med. Doctor -
Stadtberger Str.21
86157 Augsburg
Tel.: 0821/523053
86157 Augsburg
Tel.: 0821/523053
Med. Doctor/professor
Marina Kuimcheva
Med. Doctor/pediatrician, psycho-analyst, more than 10 years practical experience in Scenar treatment and Scenar related Rista diagnostic complex. Regularly teaching in The Netherlands.
Med. Doctor/pediatrician, psycho-analyst, more than 10 years practical experience in Scenar treatment and Scenar related Rista diagnostic complex. Regularly teaching in The Netherlands.
Dr. Galina Soubottina
Med. Doctor, senior teacher Scenar therapy, lecturing worldwide.
Med. Doctor, senior teacher Scenar therapy, lecturing worldwide.
Iolanta Stanchak
Med. Doctor pediatrician, head of Scenar clinic in Uzhorod/Ukrain. Over 10 years experience in Scenar practice and use of therapeutic blankets. Regularly teaching in The Netherlands.
Med. Doctor pediatrician, head of Scenar clinic in Uzhorod/Ukrain. Over 10 years experience in Scenar practice and use of therapeutic blankets. Regularly teaching in The Netherlands.
* Scenar Rusia
Petrovskaya 99, 4
* Dr. med. Gerd Köhler
Facharzt für Unfallchirurgie und Orthopädie
Facharzt für Unfallchirurgie und Orthopädie
Mittelschule und Matura in Knittelfeld / Steiermark
Medizinstudium in Graz
Ausbildung zum Unfallchirurgen im LKH Wolfsberg
Neurochirurgie, Thoraxchirurgie und Gefäßchirurgie Wien
Ausbildung zum Orthopäden: Orthopädie Graz, Laibach und München
Spezialausbildung in Neuraltherapie, Magnetfeldtherapie
Gastarzttätigkeiten als Orthopäde in Hamburg und Straßburg/ Frankreich
Skenar Therapeut, Ausbildung in Bioresonanztherapie
Medizinstudium in Graz
Ausbildung zum Unfallchirurgen im LKH Wolfsberg
Neurochirurgie, Thoraxchirurgie und Gefäßchirurgie Wien
Ausbildung zum Orthopäden: Orthopädie Graz, Laibach und München
Spezialausbildung in Neuraltherapie, Magnetfeldtherapie
Gastarzttätigkeiten als Orthopäde in Hamburg und Straßburg/ Frankreich
Skenar Therapeut, Ausbildung in Bioresonanztherapie
Kontakt
E-mail:
Dit e-mail adres is beschermd tegen spambots. U heeft Javascript nodig om het te kunnen zien.
* Praxis Drs. med. Heike und Ulrich Scherer,
Allgemeinmedizin / Naturheilverfahren
Am Iglhof 8
86444 Affing
Tel. 08207/8022
Allgemeinmedizin / Naturheilverfahren
Am Iglhof 8
86444 Affing
Tel. 08207/8022
* Dr. med. Hans Bründler
Spezialarzt FMH Innere Medizin
Praxis für Energetische Medizin
Hegibachstr. 102 / Klusplatz
CH-8032 Z ü r i c h
Tel.: 0041 1381 16 66 Fax: 0041 1422 88 07
Spezialarzt FMH Innere Medizin
Praxis für Energetische Medizin
Hegibachstr. 102 / Klusplatz
CH-8032 Z ü r i c h
Tel.: 0041 1381 16 66 Fax: 0041 1422 88 07
* Dr. Stary,
Ewald Goeckestr.7b
13055Berlin
030/9819 5777
Ewald Goeckestr.7b
13055
030/9819 5777
* Praxis Susanne Lukas (Ärztin)
Schrannenplatz 9 86830 Schwabmünchen
Schrannenplatz 9 86830 Schwabmünchen
tel : 08232/906474
Kreiskrankenhaus Wertingen
Ebersberg 36
86637 Wertingen
Tel.: 08272/ 998-304
Koordination der SCENAR-Therapie am Krankenhaus Wertingen
OA Dr. F. Brändle, Chirurg
Dit e-mail adres is beschermd tegen spambots. U heeft Javascript nodig om het te kunnen zien.
Ebersberg 36
86637 Wertingen
Tel.: 08272/ 998-304
Koordination der SCENAR-Therapie am Krankenhaus Wertingen
OA Dr. F. Brändle, Chirurg
Dit e-mail adres is beschermd tegen spambots. U heeft Javascript nodig om het te kunnen zien.
Neue Behandlungsformen im Krankenhaus Wertingen, Chirurgische Abteilung Chefarzt Dr. W. Streifinger
Seit Juni 2004 kommt im Krankenhaus Wertingen, einem Haus der Grund- und Regelversorgung mit 60 chirurgischen Betten, in der Behandlung von Knochenbrüchen routinemässig die SCENAR-Therapie zum Einsatz.
Seit Juni 2004 kommt im Krankenhaus Wertingen, einem Haus der Grund- und Regelversorgung mit 60 chirurgischen Betten, in der Behandlung von Knochenbrüchen routinemässig die SCENAR-Therapie zum Einsatz.
More references in germany
Innerhalb kurzer Zeit hat sich die SCENARtherapie von einem Nobody zu einem der Highlights in der komplementären Medizin entwickelt. Im Oktober 2002 haben die ersten 5 Ärzte in Deutschland begonnen SCENAR erfolgreich in ihren Praxen einzusetzen. Heute arbeiten ca. 5500 Therapeuten in Deutschland, Österreich und der Schweiz mit SCENAR.
Viele der Anwender stellen aus Überzeugung das SCENAR anderen Kollegen vor. Dies ist ein wesentlicher Grund für die rasche Verbreitung unseres Produktes. Unsere Referenzen reichen daher mittlerweile vom täglichen Einsatz in vielen Praxen und Reha-Kliniken bis zum Spitzensportbereich.
Nachfolgend finden Sie eine Ausschnitt der Athleten, die mit SCENAR behandelt wurden oder werden:
DTM-Mercedesteams
Mücke Motorsport
Mannschaften der Fussball-Bundesliga
Spieler von Juventus Turin
Mannschaften der österreichischen Fußball-Bundesliga
Spieler der Basketball-Bundesliga
Der deutsche Olympiakader Ringen (Athen 2004)
Weltmeisterin im Armwrestling
Die deutsche Bobmannschaft der Damen (Turin 2006)
Der Olympiastützpunkt für Kraftsport der Universität Potsdam
Olympiamannschaften Rudern
Handballbundesliga der Damen
u.v.a
Zu den mittlerweile über 5000 SCENARtherapeuten in den deutschsprachigen Ländern zählen auch folgende Institutionen:
Universität Potsdam
Universität Frankfurt Oder
Kreiskliniken Dillingen-Wertingen (Akutklinik)
LVA-Klinik Baden Baden (Rehaklinik)
LVA-Klinik Bad Wörishofen
LVA-Klinik Bad Füssing
LVA-Klinik Buching
Stauferklinik Mutlangen
Deutsche Gesellschaft für Informations- und Energiemedizin
Internationale Gesellschaft für Biologische Medizin
Internationale Gesellschaft für Energetische Medizin
Der Bund deutscher Chiropraktiker
Zentralverband der Ärzte für Naturheilverfahren
World Osteopathic Health Organization
u.v.a.
Ein weiterer Grund für den Erfolg des Produktes ist die große Patientennachfrage. Mehr als 80% aller Patienten berichten nach der Behandlung über eine Veränderung ihrer behandelten Beschwerde. Viele empfehlen deshalb diese Therapieform weiter.
Das Ergebnis: Deutliche Steigerungsraten der Selbstzahlerleistungen; neue Patienten.
Sehr positiv beurteilen die Patienten die SCENARbehandlung weil sie bei den meisten Therapien schon während oder sofort nach der Behandlung eine deutliche Dynamik feststellen können.
6 ) Literatuur
1. Grinberg Y. SCENAR-therapy: effectiveness from the position of electrotreatment methods.
SCENAR-therapy and SCENAR-expertise. Collection of articles, issue 2, pp. 18-33. Taganrog 1996.
2. Grinberg Y. To the question of grounds of SCENAR-therapy effectiveness. SCENAR-therapy and
SCENAR-expertise. Collection of articles, issue 3, pp.17-23. Taganrog
3. Bogolyubov V., Ponomarenko G. General physiotherapy. M.; 1996-480p.
4. Revenko A. Adaptive regulation (SCENAR). Theoretical and practical grounds. SCENAR-therapy
and SCENAR-expertise. Collection of articles, issue 1, pp 18-30.
5. Gorfinkel Y. theoretical and practical grounds of increase of effectiveness of SCENAR-therapy.
SCENAR-therapy and SCENAR-expertise. Collection of articles, issue 2.
6. Nozdrachev A. Physiology of vegetative nervous system. L.: ‘Medicine’, 1983, 296 p.
7. Nozdrachev A. Chemical structure of peripheral autonomous (visceral) reflex, 1996, vol.27, #2, pp 28-
60
8. Nozdrachev A. Axon-reflex. New opinions in the old field. Physiological journal named after
Sechenov I. 1992, vol. 11, pp 135-142.
9. Ashmarin I.
technology. ‘Physiology of human being and animals’, vol.34, 1988, 183 p.
10. Ashmarin I.
Journal ‘Higher nervous activity’, vol.35, #2, pp211-221.
11. Osadchyi O., Pokrovsky V. peptidergic mechanisms in parasympathetic regulation of heart rhythm.
Progress of physiologic sciences, vol.24, #3, 1993, pp 71-85.
12. Belyakov N., Solovyeva I.
sciences, vol. 23, #2, pp. 74-87.
13. Babichev V. Neuroendocrine regulation of gonadotropin and prolactin secretion and role of
neuromediators in it. Progress of physiologic sciences, vol. 26, #2, 1995 pp. 44-59.
14. Shandra A., Godlevsky L., Tkachenko I., Servetsky K., Role of black substance in mechanisms of
epileptic activity stopping. Progress of physiologic sciences, vol.26, #2, 1996, pp. 90-102.
15. Malyshenko N., Popov N., Hormones and neuropeptides – in integrative processes. Progress of
physiologic sciences, vol. 21, #2, 1990 pp. 94-106.
16. Kalyuzhny L. Heterogeneity of nociceptive and antonociceptive peptide mechanisms and their
correlation with pain genesis. Progress of physiologic sciences, vol.21, #4, pp. 68-84.
17. Zavitaev Y. SCENAR-examples of a single application of the device. SCENAR-therapy and
SCENAR-expertise. Issue 2, 1996, pp.81-82.
18. Bogdanova E., Zaidiner B. Analgetic SCENAR-therapy in oncology. SCENAR-therapy and
SCENAR-expertise. Issue 2, 1997, pp.42046.
19. Lyashedko P. Application of bioregulated electrostimulation for treatment of gastrointestinal tract
complications after severe combined damages. SCENAR-therapy and SCENAR-expertise. Issue 4,
1998.
